The Indian Council of Medical Research (ICMR) recently announced a series of landmark guidelines and policies to strengthen health services in various regions. From improving early diagnosis and treatment of chronic diseases
The Melanoma Research Alliance (MRA) is the biggest non-profit organization that funds research on melanoma globally. They have expressed their approval of the US Food and Drug Administration's (FDA) decision to authorize Iovance Biotherapeutics....
Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced that it has entered into an exclusive worldwide license agreement with Heidelberg University
Kolkata-based GPT Healthcare, which manages and operates multi-specialty hospitals under the ILS Hospitals brand, has fixed the pay band at Rs. 177- ~ Rs. 186 per share capital with a face value of Rs. 10/- each for initial public offering.
The US Food and Drug Administration (FDA) has announced that drug regulators from Goa and Telangana have joined the group of states overseeing the agency's inspections in India.
New legal guidelines for sampling medicines, cosmetics and medical devices by drug inspectors of central and state drug control agencies will bring much-needed accountability.
Iovance Biotherapeutics, Inc., a biotechnology company focused on the innovation, development and distribution of polyclonal tumor-infiltrating lymphocyte (TIL) cell therapies for cancer patients, has received approval from the US Food and Drug Admin
According to a report by Fact.MR Research, the global insulin pump market has seen significant growth in recent years due to the increasing incidence of diabetes and demand for diabetes treatment.
A blend of AstraZeneca's blockbuster cancer drug Tagrisso with chemotherapy to treat a kind of cellular breakdown in the lungs has been endorsed by the U.S. Food and Medication Organization (FDA), the organization added. The drug would be used...
Max Healthcare Institute Ltd said that it has acquired a 99.90% share in Nagpur-based Alexis Multi-Speciality Hospital Pvt Ltd for Rs 412 crore. Alexis Multi Speciality Hospital has been renamed Max Super Speciality Hospital, Nagpur, the...
, CDSCO.jpg)
.jpg)